Zobrazeno 1 - 10
of 99
pro vyhledávání: '"A, Dherai"'
Publikováno v:
Journal of clinical pharmacology. Wiley-Blackwell
Although biological agents have revolutionized the management of inflammatory bowel diseases (IBDs), a significant proportion of patients show primary non-response or develop secondary loss of response. Therapeutic drug monitoring (TDM) is advocated
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of gastroenterology and hepatologyReferences.
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease of unknown etiology, involving complex interactions between the gut microbiome and host immune response. The microbial dysbiosis is well documented in IBD and significantly influe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shilpa D Kulkarni, Tester F. Ashavaid, Ganesh R. Bhagure, Vrajesh Udani, Alpa J. Dherai, Rohan V. Lokhande
Publikováno v:
Indian Journal of Pediatrics. 88:1241-1243
Biogenic amine neurotransmitters metabolism is a multistep pathway with pterin and pyridoxal phosphate (vitamin B6) as cofactors. A defect in biogenic amine and cofactor metabolism and vesicular transporters result in a primary neurotransmitter disor
Autor:
Prasad R. Naik, Ganesh R. Bhagure, Rohan V. Lokhande, Vrajesh Udani, Tester F. Ashavaid, Neelu Desai, Alpa J. Dherai
Publikováno v:
Indian J Clin Biochem
Biogenic amine neurotransmitters such as serotonin and dopamine are essential for signaling in both central and peripheral nervous system. Their metabolism is a multistep pathway and any defect in this results in alteration in metabolites of serotoni
Publikováno v:
Journal of Clinical Pharmacology; Apr2023, Vol. 63 Issue 4, p480-489, 10p
Autor:
Dherai, Alpa J.
Publikováno v:
In Clinics in Laboratory Medicine June 2012 32(2):263-279
Publikováno v:
Indian J Clin Biochem
Advances in molecular sequencing technology has increased the diagnostic yield for Congenital disorder of glycosylation (CDG). However, novel variants or those of uncertain significance (vus) often pose a challenge and in such cases confirmed diagnos
Autor:
Tester F. Ashavaid, Dhanashri Shetty, Mihika B. Dave, Alpa J. Dherai, Devendra Desai, Satish Kulkarni, Bhamini G Keny, Kiran Peddy
Publikováno v:
Indian Journal of Gastroenterology. 39:426-434
Infliximab (IFX) monitoring has been proposed for effective therapeutic management of inflammatory bowel disease (IBD). There is no data on infliximab levels and its antibody measurement in Indian patients. We assessed the clinical efficacy of IFX le